Monopar Therapeutics
MNPR
#6871
Rank
ยฃ0.53 B
Marketcap
ยฃ79.37
Share price
-6.03%
Change (1 day)
128.79%
Change (1 year)

Revenue for Monopar Therapeutics (MNPR)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Monopar Therapeutics from 2017 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA